Sinclair Pharma selects Invida to commercialise brands in Asia Pacific

Under the collaboration agreement, Invida will be Sinclair’s exclusive partner in eleven markets within the Asia Pacific region for its dermatology and wound care brands in what is expected to be at least a 20 year partnership.

Invida will register and launch a number of Sinclair’s dermatology brands in Australia, China, Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam, in the first phase.

Invida CEO John Graham said this alliance is especially important because it closely aligns with the strategies they have been discussing throughout 2010; namely, a focus on brands that meet the needs of Asian consumers; alliances that leverage our full suite of capabilities through the pharmaceutical value chain; and the ability to promote products in multiple markets throughout the region.